Literature DB >> 20175869

Explanations for coagulation activation after air travel.

A J M Schreijer1, M F Hoylaerts, J C M Meijers, H R Lijnen, S Middeldorp, H R Büller, P H Reitsma, F R Rosendaal, S C Cannegieter.   

Abstract

SUMMARY
BACKGROUND: It is unknown whether venous thrombosis after long haul air travel is exclusively attributable to immobilization.
OBJECTIVES: We determined whether the following mechanisms were involved: hypoxia, stress, inflammation or viral infection. PATIENTS/
METHODS: In a case crossover setting in 71 healthy volunteers who were exposed to an 8-h flight, 8-h movie marathon and 8 h of regular activities, we compared markers for several hypothetical pathways: plasminogen activator inhibitor-1 (PAI-1), stress, plasma factor (F)VIII coagulant activity (FVIIIc), soluble P-selectine (sP-selectine), interleukin-8 (IL-8) and neutrophil elastase. We reported earlier an activated clotting system, as evidenced by thrombin generation, in 17% of volunteers after the flight.
RESULTS: PAI-1 increased by 4.2 ng mL(-1) (CI95:-49.5 to 6.5) in volunteers with an activated clotting system whereas it decreased in those without (-20.0 ng mL(-1), CI95:-33.2 to -14.0). FVIIIc levels rose more in individuals with clotting activation (18.0%, CI95:-1.0 to 33.0) than in those without (2.0%, CI95:-2.0 to 5.0). The increases in FVIIIc were not associated with stress, which appeared unrelated to clotting activation. sP-selectin increased in those with clotting activation (3.5 microg L(-1), CI95: -3.0 to 10.0), but decreased in those without (-0.5 microg L(-1), CI95: -2.0 to 2.0). Changes in levels of neutrophil elastase or IL-8 were not different between the subjects with and without clotting activation.
CONCLUSIONS: Our results do not support the hypotheses that stress, infection or air pollution are involved in the development of a prothrombotic state in air travellers. After long haul air travel, this state is more pronounced in patients with risk factors and may be caused by hypoxia, triggering systemic inflammation and platelet activation, leading to coagulation induction and degranulation of platelets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20175869     DOI: 10.1111/j.1538-7836.2010.03819.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  7 in total

1.  Potential for bias in case-crossover studies with shared exposures analyzed using SAS.

Authors:  Shirley V Wang; Brent A Coull; Joel Schwartz; Murray A Mittleman; Gregory A Wellenius
Journal:  Am J Epidemiol       Date:  2011-05-03       Impact factor: 4.897

Review 2.  [Physical exposure by travelling].

Authors:  U Lange
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

Review 3.  Hormonal contraception and thrombotic risk: a multidisciplinary approach.

Authors:  Cameron C Trenor; Richard J Chung; Alan D Michelson; Ellis J Neufeld; Catherine M Gordon; Marc R Laufer; S Jean Emans
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

4.  A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis.

Authors:  J Eileen Bird; Xinkang Wang; Patricia L Smith; Frank Barbera; Christine Huang; William A Schumacher
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

Review 5.  Do pregnant women have a higher risk for venous thromboembolism following air travel?

Authors:  Morteza Izadi; Mohammad Javad Alemzadeh-Ansari; Davood Kazemisaleh; Maryam Moshkani-Farahani; Akbar Shafiee
Journal:  Adv Biomed Res       Date:  2015-02-23

6.  Perioperative air travel increases the risk of venous thromboembolism following lower limb arthroplasty.

Authors:  Fahd Mahmood; Collette Harte; David Allen; Jon Clarke; Frederic Picard
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-02-18

7.  Thirty Minutes of Hypobaric Hypoxia Provokes Alterations of Immune Response, Haemostasis, and Metabolism Proteins in Human Serum.

Authors:  Jochen Hinkelbein; Stefanie Jansen; Ivan Iovino; Silvia Kruse; Moritz Meyer; Fabrizio Cirillo; Hendrik Drinhaus; Andreas Hohn; Corinna Klein; Edoardo De Robertis; Dirk Beutner
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.